The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Antheia Secures Second Project Agreement with the BioMaP-Consortium Valued at up to $12M
Dec 03, 2024•over 1 year ago
Contract Type
agreement
Menlo ParkInformation Technology
Description
Antheia announced a new government project agreement funded by the Department of Health and Human Services' (HHS) Defense Production Act (DPA) Title III Program, valued at $12 million over a two-year period. The agreement aims to accelerate domestic biomanufacturing of critical pharmaceutical ingredients and mitigate drug shortages.
Company Information
Company
Antheia, Inc.
Location
1505 O'BRIEN DRIVE, SUITE B1
Menlo Park, California, United States
About
Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines. Antheia’s team of scientists and technologists is headquartered in Menlo Park, California. For more information, visit www.antheia.bio.
Menlo ParkInformation Technology